Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Oncology
Filter     Order     Display # 
Date Item Title
13 May 2008 Affimed validates antibody target for cancer metastasis
13 May 2008 KINAXO Biotechnologies Enters Agreement with Onconova Therapeutics Inc.
13 May 2008 Active Biotech advances ANYARA into Phase III clinical trial
12 May 2008 Nventa announces additional positive immunological data from HSPE7 phase 1 Cervical Dysplasia trial
12 May 2008 Novelos Therapeutics announces positive results in ongoing phase 2 neoadjuvant breast cancer trial as Musc Hollings Cancer Center
12 May 2008 Thallion Receives Health Canada Approval to Initiate Phase II for TLN-4601 in Brain Cancer
09 May 2008 Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
09 May 2008 Dutch Authorize Manufacture of Vaccinogen’s New Cancer Vaccine
09 May 2008 Extended Accrual Time and Decreased Sample Size for OVATURE, a Multinational Phase III Clinical Study for Women With Recurrent Ovarian Cancer
08 May 2008 Cytopia announces novel anti-cancer drug development collaboration
07 May 2008 FDA and the Paul Ehrlich Institute (Germany) Approve Pluristem’s Regulatory Submissions in Support of a Phase I/II Clinical Trial Utilizing PLX-PAD for Peripheral Artery Disease
07 May 2008 ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
07 May 2008 Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
07 May 2008 Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
07 May 2008 Cleveland BioLabs Completes Recruitment for Phase II Hormone-Refractory Prostate Cancer Trial
06 May 2008 Minerva Biotechnologies Corporation Announces Major Breakthrough on New Cancer Therapy Target MUC1
05 May 2008 Curis Announces Genentech's Initiation of Hedgehog Antagonist Phase II Clinical Trial In Metastatic Colorectal Cancer
05 May 2008 MOLOGEN AG receives approval for clinical study with cancer drug MGN1703
05 May 2008 Infinity Highlights Promising Preclinical Hedgehog Data and Announces First Quarter Financial Results
02 May 2008 Celgene Cellular Therapeutics Announces Clinical Transplant of Human Placenta-Derived Stem Cells
02 May 2008 AstraZeneca Files Marketing Application in Europe for EGFR Inhibitor Gefitinib (IRESSA(TM)) in Locally Advanced Pre-Treated Non-Small Cell Lung Cancer
01 May 2008 Molecular Insight Pharmaceuticals, Inc. Initiates Phase 2a Azedra(TM) Clinical Trial in Neuroblastoma Patients
01 May 2008 Oncothyreon files investigational new drug application for PX-866 oncology compound
01 May 2008 Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in Patients with Relapsed Solid Tumors
01 May 2008 Phase I Clinical Trial of Photodynamic Therapy (PDT) Underway for Potential New Treatment of Oral Precancerous Lesions
01 May 2008 AmpliMed Corporation Announces Start of Randomized Phase 2 Trial of Amplimexon in Pancreatic Cancer
29 Apr 2008 Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
29 Apr 2008 Cougar Biotechnology Announces Initiation of Phase III Trial of CB7630 (Abiraterone Acetate)
29 Apr 2008 Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Bavituximab Phase II Breast Cancer Trial
28 Apr 2008 Medarex and Bristol-Myers Squibb Joint Statement on Submission Status of Ipilimumab
25 Apr 2008 Data suggests promising overall survival and progression-free survival with Vargatef(TM) (BIBF 1120)
24 Apr 2008 Antipodean Pharmaceuticals Announces Results of Phase 2 Study of Lead Compound MitoQ(R)
24 Apr 2008 Arana and Kyowa Hakko to co-develop anti-cancer drug
24 Apr 2008 PharmaGap Reports Positive Early Results For Next Drug Compound
23 Apr 2008 Micromet Enrolls First Patient in Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
23 Apr 2008 Oral PBI-1402 Demonstrates Significant Activity in Chemeotherapy-Induced Anemia Phase II Clinical Trial
23 Apr 2008 Cytheris Announces New Phase I Study of Interleukin-7 As Immunotherapy In Treatment of Bone Marrow or Peripheral Blood Stem Cell Transplant Patients
22 Apr 2008 ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer
22 Apr 2008 Lorus initiates development program exploring novel route of administration for LOR-2040
22 Apr 2008 Allos Therapeutics Completes Patient Enrollment in Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
22 Apr 2008 Biovex agrees SPA with the FDA for a pivotal study with ONCOVEXGM-CSF in metastatic melanoma and announces presentation of phase II results at ASCO
22 Apr 2008 Human Genome Sciences completes enrollment in first of two phase 3 LYMPHOSTAT-B(R) trials
21 Apr 2008 Cancer Treatment Pioneer, Lpath, Initiates Dosing in Phase 1 Cancer Trial
21 Apr 2008 Thalidomide Pharmion(TM) Granted Full Marketing Authorization for Treatment of Newly Diagnosed Multiple Myeloma in the European Union
21 Apr 2008 Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic
21 Apr 2008 Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
20 Apr 2008 Genentech Provides Update on "AVAiL" Phase III Study of Avastin Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small Cell Lung Cancer
18 Apr 2008 Nereus Pharmaceuticals Initiates Combination Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors
18 Apr 2008 Aida Announces New Anti-Cancer Drug Under Development
17 Apr 2008 Cytokinetics Announces Selection of Development Compound that Activates the Skeletal Sarcomere
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 451 - 500 of 2757

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics